Juvenile angiofibroma: sixteen years experience

Authors

  • Carla d'Espiney Amaro Médica dos Quadros da Marinha, Interna do complementar ORL no Hospital de São José, Portugal
  • Pedro Montalvão Assistente Hospitalar Graduado de ORL do IPO de Lisboa, Portugal
  • Miguel Magalhães Chefe de Serviço de ORL do IPO de Lisboa, Portugal
  • Lucian Rhadu Professor Auxiliar da Faculdade de Engenharia da Universidade Católica Portuguesa, Portugal
  • Nuno Santiago Professor, Director Jubilado do Serviço de ORL do IPO de Lisboa, Portugal
  • João Olias Professor, Director do Serviço de ORL do IPO de Lisboa, Portugal

DOI:

https://doi.org/10.34631/sporl.33

Keywords:

juvenile angiofibroma, embolization, persistence, recurrence

Abstract

Objective: To analyze the activity of the IPOLFG-EPE service of ENT related to angiofibroma; to determine if embolization is a factor which interferes with tumor persistence/ recurrence.

Patients and methods: Retrospective study of 28 patients submitted to surgery for juvenile angiofibroma in the years 1990 to 2007. Statistical analysis was made with Spearman study Results: Five patients had tumour in stage IA, one patient in stage IB, one in stage IIA, 3 in stage 118, 7 in stage IIIA, 2 in stage BIB and four had no defined stage. Embolization was performed in 51.7% patients, After initial treatment, there was 25.9% of persistence and 11.1% of recurrence. After a second surgery, there was 18.5% of persistence/recurrence. Correlation between embolization and persistence was not statistical significant (p = 0.086).

Conclusion: Juvenile angiofibroma is diagnosed in late stages. In this study, embolization has no influence in tumour persistence.

Downloads

How to Cite

Amaro, C. d'Espiney, Montalvão, P., Magalhães, M., Rhadu, L., Santiago, N., & Olias, J. (2009). Juvenile angiofibroma: sixteen years experience. Portuguese Journal of Otorhinolaryngology and Head and Neck Surgery, 47(1), 16–24. https://doi.org/10.34631/sporl.33

Issue

Vol. 47 No. 1 (2009): Março

Section

Review